hasApprovedDrug

URI: https://gptkb.org/prop/hasApprovedDrug
109 triples
GPTKB property
Alternative names (3)
approvedDrug • approvedDrugForm • firstApprovedDrug
Random triples
Subject Object
gptkb:Non-Small_Cell_Lung_Cancer gptkb:Gemcitabine
gptkb:Non-Small_Cell_Lung_Cancer gptkb:Paclitaxel
gptkb:T_Cell_Therapy gptkb:Kymriah
gptkb:PI3Kα_Inhibitors gptkb:Alpelisib
gptkb:Non-Small_Cell_Lung_Cancer gptkb:Pralsetinib
gptkb:Non-Small_Cell_Lung_Cancer gptkb:Capmatinib
gptkb:ACTH cosyntropin
gptkb:BRAF_inhibitors gptkb:dabrafenib
gptkb:Non-Small_Cell_Lung_Cancer gptkb:Bevacizumab
gptkb:Non-Small_Cell_Lung_Cancer gptkb:Vinorelbine
gptkb:Non-Small_Cell_Lung_Cancer gptkb:Camrelizumab
gptkb:Vertex_Pharmaceuticals_Incorporated gptkb:Kalydeco
gptkb:EGFR_mutation-positive_NSCLC gptkb:afatinib
gptkb:SGLT2_inhibitors gptkb:empagliflozin
gptkb:Non-Small_Cell_Lung_Cancer gptkb:Gefitinib
gptkb:Non-Small_Cell_Lung_Cancer gptkb:Alpelisib
gptkb:plasminogen_activator,_tissue_type gptkb:alteplase
gptkb:Immune_Checkpoint_Blockade gptkb:Ipilimumab
gptkb:EGFR_mutation-positive_NSCLC gptkb:erlotinib
gptkb:NRTI gptkb:zidovudine